Northwestern Capital Partners, LLC has been engaged to raise capital for Power2Practice, a Chicago-based SasS platform for the unique requirements integrative health providers and patients. Integrative medicine looks at the entire patient, integrating best practices and the foremost therapeutics from the pharmaceutical industry, compound pharmacy, pharmaceutical grade supplements, dietary guidelines, and exercise regimens. P2P’s focus is on the integrative health care market, a sizable and distinctive niche in the private physician space that is not served by other EMR platforms.
P2P has bundled the SaaS-based EMR platform with other vital services, including a GPO component in a venture with Provista, one of the country’s largest GPOs, and other vital services such as supplement procurement, accounting and billing, specialty practices, compound pharmacy ordering, and other essential components to a profitable healthcare practice. P2P provides the tool kit to a potential group of 90,000 physicians.
The result is a fast growing and unique platform with over 1,300 physicians and strong MRR rates and customer stickiness. The company is seeking additional capital of $4.2mm to help further accelerate its successful market launch. The company has raised significant capital to gain its current traction in the market.
Northwestern Capital is an investor in SPLT, a rideshare mobility program based in Detroit, has recently signed an investment agreement with InMotion Ventures, the strategic investment arm of Jaguar Land Rover. NCP is also leading their move into non-emergency medical transport, with pending strategic agreements with one of the largest healthcare systems in the Midwest, and their wholly owned EMS subsidiary. NCP has invested with the parent company since 2010.
HealthCure, LLC, a company in which NCP is an investor and managing partner, completed a study with Genesys Health, which part of Ascension Health (the US’ largest non-profit healthcare system with $25 billion of revenues). The study centered on the efficacy of HealthCure’s prophylactic surface treatment, which reduces bacterial contamination for 30 days. The results were conclusively positive and the company is seeking to expand its market.
Northwestern Capital Partners, LLC advised Physician’s Choice Laboratory Services on their molecular diagnostics business to a private equity backed strategic buyer. The total sales value was $21 million. Northwestern Capital Partners established the valuation, marketed the company, and found the purchaser.